Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karoline Ehlert

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal for Immunotherapy of Cancer|May 17, 2020
Nivolumab and dinutuximab beta in two patients with refractory neuroblastomaKaroline Ehlert, Ina Hansjuergens, Andreas Zinke, et al.
Journal of the Pediatric Infectious Diseases Society|August 11, 2021
Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus InfectionsKaroline Ehlert, Johannes H Schulte, Jörn-Sven Kühl, et al.
The Journal of Pediatrics|January 15, 2004
Successful hematopoietic stem cell transplantation in Farber diseaseJosef Vormoor, Karoline Ehlert, Andreas H Groll, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2008
Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipientsKatherine Allinson, Hedwig Kolve, Hans G Gumbinger, et al.
Deutsches Arzteblatt International|February 26, 2014
Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-upGünther Schellong, Marianne Riepenhausen, Karoline Ehlert, et al.
Mycoses|October 30, 2019
Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantationChristina Linke, Karoline Ehlert, Martina Ahlmann, et al.
British Journal of Cancer|October 9, 2023
Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 studyHolger N Lode, Karoline Ehlert, Stephanie Huber, et al.
Journal of Neurosurgery. Case Lessons|June 24, 2023
Rare clival localization of an eosinophilic granuloma: illustrative caseMartin E Weidemeier, Steffen Fleck, Werner Hosemann, et al.
Frontiers in Pediatrics|January 4, 2021
Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based ImmunotherapyFiliz Cicek, Sascha Troschke-Meurer, Kiraz Ceylan, et al.
Pediatric Blood & Cancer|January 20, 2018
Inflammatory response and treatment tolerance of long-term infusion of the anti-GD<sub>2</sub> antibody ch14.18/CHO in combination with interleukin-2 in patients with high-risk neuroblastomaKiraz Ceylan, Luciana J Jahns, Bjoern N Lode, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal for Immunotherapy of Cancer|May 17, 2020
Nivolumab and dinutuximab beta in two patients with refractory neuroblastomaKaroline Ehlert, Ina Hansjuergens, Andreas Zinke, et al.
Journal of the Pediatric Infectious Diseases Society|August 11, 2021
Efficacy of Brincidofovir in Pediatric Stem Cell Transplant Recipients With Adenovirus InfectionsKaroline Ehlert, Johannes H Schulte, Jörn-Sven Kühl, et al.
The Journal of Pediatrics|January 15, 2004
Successful hematopoietic stem cell transplantation in Farber diseaseJosef Vormoor, Karoline Ehlert, Andreas H Groll, et al.
The Journal of Antimicrobial Chemotherapy|February 2, 2008
Secondary antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell recipientsKatherine Allinson, Hedwig Kolve, Hans G Gumbinger, et al.
Deutsches Arzteblatt International|February 26, 2014
Breast cancer in young women after treatment for Hodgkin's disease during childhood or adolescence--an observational study with up to 33-year follow-upGünther Schellong, Marianne Riepenhausen, Karoline Ehlert, et al.
Mycoses|October 30, 2019
Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantationChristina Linke, Karoline Ehlert, Martina Ahlmann, et al.
British Journal of Cancer|October 9, 2023
Long-term, continuous infusion of single-agent dinutuximab beta for relapsed/refractory neuroblastoma: an open-label, single-arm, Phase 2 studyHolger N Lode, Karoline Ehlert, Stephanie Huber, et al.
Journal of Neurosurgery. Case Lessons|June 24, 2023
Rare clival localization of an eosinophilic granuloma: illustrative caseMartin E Weidemeier, Steffen Fleck, Werner Hosemann, et al.
Frontiers in Pediatrics|January 4, 2021
Impact of IL-2 on Treatment Tolerance in Patients With High-Risk Neuroblastoma Treated With Dinutuximab Beta-Based ImmunotherapyFiliz Cicek, Sascha Troschke-Meurer, Kiraz Ceylan, et al.
Pediatric Blood & Cancer|January 20, 2018
Inflammatory response and treatment tolerance of long-term infusion of the anti-GD<sub>2</sub> antibody ch14.18/CHO in combination with interleukin-2 in patients with high-risk neuroblastomaKiraz Ceylan, Luciana J Jahns, Bjoern N Lode, et al.
Pageof 5